Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
MedTech
FDA flags review of Telix's radiodiagnostic for kidney cancer
The FDA has asked Telix for more information about the manufacturing of its novel PET agent for clear-cell renal cell carcinoma.
Conor Hale
Aug 28, 2025 11:20am
Radiopharma biotech Artbio paints path to clinic with $132M
Jul 29, 2025 7:30am
Nuclidium raises $99M for copper-based radiopharma pipeline
Jul 10, 2025 5:04am
BerGenBio, following lead drug's failure, merges with Oncoinvent
Jul 1, 2025 7:00am
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
Jun 27, 2025 9:45am
BMS expands radiopharma pipeline
Jun 11, 2025 4:31am
